Receptors for oestrogen (ER) and progesterone (PR) were assayed in tissue from 17
patients with colorectal cancer and five colonic cancer cell lines using enzyme …

Results In gastric cancer, ER were detected in 62.5% and PR in 75% of the patients. In
colorectal cancer, the ER and PR were detected in 60% of the patients. The binding activity …

Estradiol receptor (ER) and progesterone receptor (PgR) were assayed in tumors from 20
patients with primary colorectal cancer. Ten of 20 tumors contained high affinity sites for 17β …

The measurement of estrogen as well as progesterone receptors has been applied clinically
to predict the effectiveness of endocrine therapy in patients with breast or endometrial …

The oestrogen receptor content of colorectal adenocarcinoma was investigated using an
established ligand binding biochemical assay and two more recently introduced techniques …

Estrogen receptors have been found in normal and neoplastic gastrointestinal mucosa. The
aim of our study was to verify whether the content of cytosolic estrogen receptor in normal …

Estrogen and progesterone receptors were studied in 70 cases of human colorectal cancer
by a cytochemical technique. 28.5% of the cases were estrogen-receptor positive and 42.8 …

Expression of sex steroid receptors by gastrointestinal (GI) tumours may indicate a role for
hormonal manipulation in their management. A panel of seven established cell lines derived …

Adenocarcinomas of the large bowel in 28 consecutive patients were examined for the
presence of estrogen and progestin receptor proteins. None of the specimens showed …

Increased expression of oestrogen (ER) and progesterone (PR) receptors have been
reported in gastric adenocarcinoma, although results have been variable …